Financial Results
Alexandria Pharmaceuticals (AXPH.CA) Reports Year Ended 30/06/2026 Results
Published at 28 September 2026 at 12:20Alexandria PharmaceuticalsRelated stock:Alexandria Pharmaceuticals stockAll Alexandria Pharmaceuticals disclosures
Disclosure summary
Company Name : Alexandria Pharmaceuticals
ISIN Code : EGS38341C011
Currency : EGP
F/S Period : From 01/07/2025 To 30/06/2026
Net Profit : 524,799,762
F/S Period: From 01/07/2024 To 30/06/2025
Net Comparative Profit : 391,169,831
Audit Status : Audited
Source : Alexandria Pharmaceuticals
The Annual BoD Report in Arabic & English (2,292 KB)
The Corporate Governance Report in Arabic & English (2,127 KB)
The Sustainability Report in Arabic & English (1,839 KB)
ISIN Code : EGS38341C011
Currency : EGP
F/S Period : From 01/07/2025 To 30/06/2026
Net Profit : 524,799,762
F/S Period: From 01/07/2024 To 30/06/2025
Net Comparative Profit : 391,169,831
Audit Status : Audited
Source : Alexandria Pharmaceuticals
The Annual BoD Report in Arabic & English (2,292 KB)
The Corporate Governance Report in Arabic & English (2,127 KB)
The Sustainability Report in Arabic & English (1,839 KB)